-+ 0.00%
-+ 0.00%
-+ 0.00%

Immunome Phase 3 RINGSIDE varegacestat data set for ASCO oral presentation

PUBT·04/21/2026 14:34:57
Listen to the news
Immunome Phase 3 RINGSIDE varegacestat data set for ASCO oral presentation
  • Immunome disclosed Phase 3 RINGSIDE trial data for varegacestat in progressing desmoid tumors was selected for oral presentation at 2026 ASCO Annual Meeting.
  • Detailed results will be presented in future, building on positive topline data released in December 2025.
  • Trial outcome supports varegacestat as a potential new treatment option for patients with desmoid tumors.
  • Presentation is scheduled for May 30, 2026, in ASCO oral abstract session on sarcoma.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief on April 21, 2026, and is solely responsible for the information contained therein.